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Infection of cells with the human immunodeficiency virus type-l (HIV-l) usually results in the formation of giant multinu- 
clear cells (syncytia) [(1986) Nature 322, 47&474; (1986) Nature 322, 725728; (1985) Hum. Pathol. 18, 760-765; (1987) 
Ann. Neurol. 21, 49&496]. The appearance of syncytia is associated with an increase in the monounsaturated oleic acid 
content. This report describes experiments which compare the activity of known antiviral agents with that of saturated 
fatty acid derivatives in inhibiting oleic acid and syncytia formation. A concept is introduced which proposes that infec- 
tion of cells with the human immunodeficiency virus causes a rise in cellular oleic acid which leads to increased membrane 
fluidity. 
Antiviral therapy; Fatty acid; HIV; (Syncytia) 
1. INTRODUCTION 
A range of cytopathic effects (CPE) are induced 
by viruses in vitro. The two most common types of 
CPE observed are those caused by the ‘lytic’ 
viruses which produce a rounding and detachment 
of adherent cells from the culture substratum; and 
those viruses described as ‘fusogenic’ which induce 
syncytia formation. These phenomena usually 
precede cell death. These effects are associated 
with significant changes in stearic (C18:O; m.p. 
69°C) and oleic acid (C18:l; m.p. 13.9”C) acid 
metabolism of the host cell [5-81. In mammalian 
cells the balance between these two fatty acids is 
controlled by the enzyme complex A-9-desaturase 
whereby the monounsaturated oleic acid is pro- 
duced by desaturation of the stearic acid [9]. The 
stearic to oleic acid ratio is designated as the 
saturation index (SI) [lo]. This index decreases in 
cells infected with fusogenic viruses (i.e. a rise in 
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the oleic acid content is observed) and increases 
with lytic viruses [5-81. The data show that AZT, 
a-interferon and dihydroxy stearic acid reduce the 
desaturation of stearic acid in cells infected with 
HIV when compared with untreated infected con- 
trols. The known inhibitory effect of AZT [l l] and 
a-interferon [12] on HIV replication supports the 
concept that unrestrained HIV infection in tissue 
culture disturbs the stearic/oleic balance of cell 
membranes, an effect which may play a part in fu- 
sion and cell death. 
2. METHODS 
2.1. Lipid extraction 
Lipids were extracted by a modification of the Folch method 
[13]. Briefly free fatty acids were liberated by alkali saponifica- 
tion with 15% (w/v) methanolic potassium hydroxide and 
followed by acidification with 4 M hydrochloric acid; methyl 
esters were produced by reaction with freshly prepared 
diazomethane. Fatty acid methyl esters (FAMES) were resolved 
by gas-liquid chromatography on a 2 m x 2 mm i.d. silanized 
glass column packed with 3% SP-2310/2% SP-2300 on 
chromosorb WAW (Supelco Chromatography Supplies). A 
temperature programme of 160°C to 260°C at 4”C.min-‘, with 
nitrogen at 20 ml. min-’ as the carrier gas, was used. Detection 
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was by flame ionisation and individual FAMES were identified 
and quantitated by comparison of retention times and co- 
chromatography, with authenticated FAME standards (Sigma 
Chemical Co. Ltd). 
2.2. Virus culture 
HIV 1 (HTLV III RF) was grown in H9 cells with RPM1 sup- 
plemented with 10% fetal calf serum (FCS). Cell debris was 
removed by low speed centrifugation and the virus was stored 
at -70°C until required. C8166 lymphoid cells were infected 
with 1OTCIDso HTLVIII (RF) for 1.5 h. For each kinetic ex- 
periment approximately 10’ cells in 15 ml of medium were 
cultured in the presence of either 10rM azido-thymidine 
(AZT), Roche Products UK Ltd; 104 U/ml a-interferon (ru- 
IFN), Wellcome; or 1OOpM dihydroxy stearic acid (DHSA), 
Cadburys for 48 h. Infected and uninfected cells were included 
as controls. At 18, 24 and 40 h, lo6 cells (triplicate samples) 
were removed from each culture, washed three times in 
phosphate buffered saline (PBSA) and the cell pellet stored at 
- 20°C until analysed. These experiments were carried out on 
three different occasions. 
2.3. HIV antigen detection 
To assay for anti-HIV activity of DHSA, C8166 cells were in- 
cubated with 1OTCIDsa HTLV III(RF) at 37°C for 1.5 h. The 
cells were washed with PBSA three times and 2 x 10s cell ali- 
quots were resuspended in 1.5 ml growth medium in the 
presence of 25, 50 and 1OOpM DHSA and incubated at 37°C 
for 72 h in a 5% COz/95% air atmosphere. An antigen capture 
ELISA [I41 was used to measure HIV in the supernatants aken 
from the cultures using the steps described by the manufac- 
turers (Organon Teknica). Uninfected and infected untreated 
controls were included. 
3. RESULTS AND DISCUSSION 
Table 1 shows the changes in fatty acid composi- 
tion of the C8166 cells at various times after infec- 
tion with HIV-l. The combined values of stearic 
and oleic acids (SUM) constitute 60% of the total 
resolvable fatty acids: this value remains constant 
throughout the time course of the experiment but 
the increase in the unsaturated oleic acid (18: 1) 
relative to stearic acid (18:0) rises by up to 50%. 
All the other fatty acid components show no 
significant change during the same time course. In 
fig.la the changes in the proportion of these two 
fatty acids in cells infected with HIV are presented 
as the SI; the depression in the SI coincides with 
the appearance of syncytia at about 40 h post- 
Table 1 
Profile for the fatty acids present in infected C8166 CD4+ cells at various 
times post-infection 
Time (h) 16:0 16:l 18:0 18:l Sum 18:2 18:3 20.4 Other 
0 26 0.6 23.4 31.1 54.4 2.3 9.5 3.7 3.4 
18 19.5 2.7 22.1 36.2 58 1.8 1.4 0 16.3 
24 17 1.3 16.2 46.2 62 5.7 0.6 1.9 11.1 
40 17.2 2.4 13.3 45.9 59.2 4.9 1.5 1.6 13.2 
0 15.1 1.7 31.5 32.8 64.3 5.2 1.7 6.1 5.9 
18 26.3 1.7 30.1 30.4 60.5 3.6 0.9 3.6 3.4 
24 15.3 0.8 25.3 38.8 64.1 5.1 1.1 2.2 11.4 
40 15 1.4 6.1 55.4 61.5 4.8 0.5 7.5 9.3 
0 21.8 1.7 25.4 33.2 58.6 2.2 0.7 7.9 7.2 
18 14 4.7 18.2 32.1 50.3 4.8 2.7 12.1 11.3 
24 15.6 2.8 17.3 38.9 56.2 4.8 1.7 8.9 9.8 
40 21.1 2.7 13.2 41.4 54.6 4.3 1.8 7.6 7.4 
X 18.66 2.04 20.18 38.53 58.64 4.13 2.01 5.25 9.14 
SD 4.29 1.11 7.18 7.59 4.21 1.32 2.44 3.63 3.87 
Three separate xperiments are represented. The mean (X) and the standard 
deviation (SD) for stearic plus oleic acids (SUM: 18:0 $ 18:l) is 58.64 + 4.21, 
whereas the values for stearic and oleic acids are 20.18 + 7.18 and 38.53 f 
7.59, respectively. The % fatty acid composition was calculated for all of the 
58 samples analysed in this series of experiments (including the values for 
infected cells treated with AZT, DHSA and (u-IFN). The mean for stearic acid 
plus oleic acid for all 58 samples is 59.45 f 4.13. These values are the same 
as those obtained for stearic plus oleic acids (SUM) from infected cells which 
are listed in this table 
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Fig.1. These show the change in saturation index of HIV 
infected C8166 cells in the presence of AZT (a), wIFN (a) and 
DHSA (b). C, uninfected cells; AZT+V, HIV-infected cells 
treated with AZT; IFN+V, HIV-infected cells treated with 
(u-IFN; DHSA, uninfected cells treated with DHSA; 
DHSA + V, infected cells treated with DHSA; V, HIV-infected 
cells. 
infection and the SI remains at a low value (0.25). 
This result indicates that the increase in oleic acid 
with the presumed increase in membrane fluidity is 
associated with the fusogenic effect of HIV. This 
concept is supported by the data for the antiviral 
agents [Ill AZT and (u-IFN [12] (fig-la): both 
compounds when added to infected cultures reduce 
the extent of desaturation of stearic acid and syn- 
cytia formation. The SI of the uninfected cells 
(1.1) does not fall during the same period (fig.la) 
and no changes in cell morphology are observed. 
These changes in the membrane composition could 
explain the recent observation that bile salts have 
a selective effect on HIV-infected cells [15]. 
Saturated fatty acids, which are known to 
decrease membrane fluidity [16], were added to the 
culture media of infected cells. Stearic acid and its 
derivatives iodostearic, epoxystearic, sterculic and 
DHSA all showed a degree of activity in reducing 
syncytia formation. DHSA was chosen for a 
detailed study because it was found to be the most 
active compound. The addition of 100 PM DHSA 
to the culture media of infected cells reduced 
desaturation (fig. lb) and inhibited syncytia forma- 
tion when compared to the infected untreated con- 
trols. Moreover, when DHSA was added to 
uninfected cells a rise in the saturation index 
(> 1.6) was observed (fig. lb). Thus the addition of 
DHSA to both uninfected and infected cultures 
produces a rise in the SI when compared to both 
untreated controls. 
The inhibitory effect of DHSA on HIV antigen 
production was measured in a standard assay [14] 
on five occasions (data not shown); at 100/1M 
there is a 78% inhibition. At this concentration 
DHSA had a slight cytostatic effect; however this 
effect disappeared when fresh media lacking 
DHSA was added to the cells. At 50 ,uM DHSA, a 
30% inhibition of HIV antigen production was 
measured and no toxicity was observed. 
These data show that HIV infection of C8166 
cells produces a marked desaturation of cellular 
stearic acid into oleic acid which coincides with the 
appearance of syncytia. This process can be in- 
hibited by AZT, wIFN and DHSA, although the 
mode of action of each compound will be dif- 
ferent: AZT and wIFN are likely to have an effect 
on HIV replication whereas DHSA would appear 
to act on the infected cell membranes. HIV infec- 
tion is known to be linked with changes in 
phospholipid metabolism [17]; further, increases 
in cell permeability and membrane fluidity occur in 
plasma membranes of neuroblastoma cells which 
have increased levels of oleic acid [ 181. Thus HIV 
cytopathology may be dependent not only on the 
interaction between the gp120 surface glycoprotein 
[1,2] and the CD4 receptor molecules [19,20] but 
on changes in membrane fluidity and perhaps 
other, as of yet, unidentified factors 1211. 
In conclusion, it is proposed that the formation 
of syncytia is at least a two stage process. Firstly, 
HIV glycoproteins and cell receptors form a bridge 
between adjacent cell membranes; secondly, cell 
fusion is facilitated by an increase in membrane 
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fluidity due to the increase in cellular oleic acid. 
Cell death may be caused by the loss of plasma 
membrane integrity due to excessive stearic acid 
desaturation into oleic acid. Finally, it is 
postulated that HIV after infection of its target cell 
enhances the activity of the A-Pdesaturase enzyme 
complex by an unknown mechanism. Inhibitors of 
this enzyme could prove to be useful in preventing 
cell damage caused by HIV infection [22]. 
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